Candriam S.C.A. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 159 filers reported holding IMMUNOMEDICS INC in Q3 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$9,044,000
-77.4%
106,369
-90.6%
0.08%
-79.9%
Q2 2020$40,001,000
+260.1%
1,128,632
+110.1%
0.42%
+243.1%
Q1 2020$11,109,000
-2.2%
537,074
+0.0%
0.12%
+0.8%
Q4 2019$11,364,000
+75.2%
537,037
+9.8%
0.12%
+41.9%
Q3 2019$6,488,000
-35.7%
489,300
-33.0%
0.09%
-31.7%
Q2 2019$10,086,000
-43.9%
730,400
-22.0%
0.13%
-45.2%
Q1 2019$17,979,000
+40.6%
935,887
+4.4%
0.23%
+16.8%
Q4 2018$12,791,000
-65.2%
896,376
-49.2%
0.20%
-59.7%
Q3 2018$36,775,000
+110.5%
1,765,500
+139.2%
0.49%
+77.2%
Q2 2018$17,469,000
+100.3%
738,000
+23.6%
0.28%
+85.2%
Q1 2018$8,723,000
-2.7%
597,000
+7.6%
0.15%
-3.9%
Q4 2017$8,969,000
+29.7%
555,000
+12.2%
0.16%
+28.1%
Q3 2017$6,913,000
+42.3%
494,500
-10.1%
0.12%
+33.0%
Q2 2017$4,857,000
+47.2%
550,000
+7.8%
0.09%
+42.2%
Q1 2017$3,300,000
+669.2%
510,000
+175.7%
0.06%
+481.8%
Q2 2016$429,000
-68.0%
185,000
-43.9%
0.01%
-60.7%
Q2 2015$1,340,000
-33.4%
330,000
-37.1%
0.03%
-31.7%
Q1 2015$2,011,000
-33.0%
525,000
-16.0%
0.04%
-34.9%
Q4 2014$3,000,000625,0000.06%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders